Overview
Multiply Labs develops cloud-controlled modular robotic systems that automate biomanufacturing for cell and gene therapies, integrating with GMP instruments for high-throughput production. These systems enable scalable manufacturing of personalized therapies in pharma facilities, reducing costs by up to 74% and minimizing contamination risks. They collaborate with leaders like AstraZeneca, Thermo Fisher, and NVIDIA to deploy robotics in cleanrooms for precision medicine.
Frequently asked questions
- What manufacturing capabilities does Multiply Labs offer?
- Cloud-controlled modular robotic systems for automating cell and gene therapy production, integrating GMP instruments for high-throughput, parallel processing of personalized therapies.
- Are Multiply Labs' systems GMP-compliant and regulatory-ready?
- Yes, their robotic biomanufacturing systems are GMP-ready, designed for clinical and commercial-scale use while maintaining quality and regulatory standards.
- What geographies does Multiply Labs serve?
- Based in San Francisco, CA, they deploy systems in pharma customer facilities worldwide, partnering with global companies like AstraZeneca and Thermo Fisher Scientific.